Head to Head Analysis: Accelera Innovations (OTCMKTS:ACNV) versus UpHealth (NYSE:UPH)

Accelera Innovations (OTCMKTS:ACNVGet Rating) and UpHealth (NYSE:UPHGet Rating) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Valuation and Earnings

This table compares Accelera Innovations and UpHealth’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Accelera Innovations N/A N/A N/A N/A N/A
UpHealth $123.79 million 0.83 -$340.90 million N/A N/A

Accelera Innovations has higher earnings, but lower revenue than UpHealth.

Profitability

This table compares Accelera Innovations and UpHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Accelera Innovations N/A N/A N/A
UpHealth N/A -20.87% -13.01%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Accelera Innovations and UpHealth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accelera Innovations 0 0 0 0 N/A
UpHealth 0 1 4 0 2.80

UpHealth has a consensus target price of $8.38, suggesting a potential upside of 1,071.00%. Given UpHealth’s higher probable upside, analysts plainly believe UpHealth is more favorable than Accelera Innovations.

Risk and Volatility

Accelera Innovations has a beta of 5.48, suggesting that its share price is 448% more volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500.

Insider & Institutional Ownership

13.1% of UpHealth shares are held by institutional investors. 20.8% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

UpHealth beats Accelera Innovations on 5 of the 8 factors compared between the two stocks.

Accelera Innovations Company Profile (Get Rating)

Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company's Accelera Technology, an Internet-based software platform enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. It also provides billing, practice management, and administrative services to doctors and other clinicians, as well as home health services to patients in Chicago. The company was formerly known as Accelerated Acquisitions IV, Inc. and changed its name to Accelera Innovations, Inc. in October 2011. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado.

UpHealth Company Profile (Get Rating)

UpHealth, Inc. operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; MedQuest Pharmacy, a full-service retail and compounding pharmacy licensed that dispenses prescribed medications shipped directly to patients; and Telehealth solutions. The company is based in Delray Beach, Florida.

Receive News & Ratings for Accelera Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelera Innovations and related companies with MarketBeat.com's FREE daily email newsletter.